Anaconda Pharma, Biota Pharmaceuticals deal

Biota completed its acquisition of Anaconda for $8 million in cash and 3.5 million Biota shares, valued at $7.5 million based on Biota’s close of $2.15 on June 2, before the deal closed (see BioCentur...